Many researchers have attempted to control chronic virus infection using immunotherapeutic interventions such as blockade of the inhibitory receptors PD–1 and CTLA–4, administration of type I IFN, and regulation of microRNAs [32] [33,34]. Here, CTLA4 is linked to viral infectious disease.